Whipple’s disease: a fatal mimic
Benjamin Kukull; Jonathon Mahlow; Gillian Hale; Lindsey J. Perry
Abstract
Keywords
References
1 Bennett JDR, Blaser J. Mandell Douglas and Bennett’s principles and practice of infectious diseases. 9th ed. Philadelphia: Elsevier; 2019.
2 Fenollar F, Trani M, Davoust B, et al. Prevalence of asymptomatic Tropheryma whipplei carriage among humans and nonhuman primates. J Infect Dis. 2008;197(6):880-7.
3 Marth T, Moos V, Müller C, Biagi F, Schneider T. Tropheryma whipplei infection and Whipple’s disease. Lancet Infect Dis. 2016;16(3):e13-22.
4 Schöniger-Hekele M, Petermann D, Weber B, Müller C. Tropheryma whipplei in the environment: survey of sewage plant influxes and sewage plant workers. Appl Environ Microbiol. 2007;73(6):2033-5.
5 Elchert JA, Mansoor E, Abou-Saleh M, Cooper GS. Epidemiology of Whipple’s disease in the USA Between 2012 and 2017: A Population-Based National Study. Dig Dis Sci. 2019;64(5):1305-11.
6 Durand DV, Lecomte C, Cathébras P, Rousset H, Godeau P. Whipple disease: clinical review of 52 cases. Medicine. 1997;76(3):170-84.
7 Lagier JC, Lepidi H, Raoult D, Fenollar F. Systemic Tropheryma whipplei: clinical presentation of 142 patients with infections diagnosed or confirmed in a reference center. Medicine. 2010;89(5):337-45.
8 Puéchal X. Whipple disease and arthritis. Curr Opin Rheumatol. 2001;13(1):74-9.
9 Dolmans RA, Boel CH, Lacle MM, Kusters JG. Clinical manifestations, treatment, and diagnosis of Tropheryma whipplei Infections. Clin Microbiol Rev. 2017;30(2):529-55.
10 Ehrbar HU, Bauerfeind P, Dutly F, Koelz HR, Altwegg M. PCR-positive tests for Tropheryma whippelii in patients without Whipple’s disease. Lancet. 1999;353(9171):2214.
11 Panegyres PK. Diagnosis and management of Whipple’s disease of the brain. Pract Neurol. 2008;8(5):311-7.
12 Fenollar F, Célard M, Lagier JC, Lepidi H, Fournier PE, Raoult D. Tropheryma whipplei endocarditis. Emerg Infect Dis. 2013;19(11):1721-30.
13 Geissdörfer W, Moos V, Moter A, et al. High frequency of Tropheryma whipplei in culture-negative endocarditis. J Clin Microbiol. 2012;50(2):216-22.
14 Glaser C, Rieg S, Wiech T, et al. Whipple’s disease mimicking rheumatoid arthritis can cause misdiagnosis and treatment failure. Orphanet J Rare Dis. 2017;12(1):99.
15 Ojeda E, Cosme A, Lapaza J, Torrado J, Arruabarrena I, Alzate L. Whipple’s disease in Spain: a clinical review of 91 patients diagnosed between 1947 and 2001. Rev Esp Enferm Dig. 2010;102(2):108-23.
16 Bentley SD, Maiwald M, Murphy LD, et al. Sequencing and analysis of the genome of the Whipple’s disease bacterium Tropheryma whipplei. Lancet. 2003;361(9358):637-44.
17 Raoult D, Birg ML, La Scola B, et al. Cultivation of the bacillus of Whipple’s disease. N Engl J Med. 2000;342(9):620-5.
18 Rolain JM, Fenollar F, Raoult D. False positive PCR detection of Tropheryma whipplei in the saliva of healthy people. BMC Microbiol. 2007;7(1):48.
19 Mahnel R, Kalt A, Ring S, Stallmach A, Strober W, Marth T. Immunosuppressive therapy in Whipple’s disease patients is associated with the appearance of gastrointestinal manifestations. Am J Gastroenterol. 2005;100(5):1167-73.
20 Marth T. Complicated Whipple’s disease and endocarditis following tumor necrosis factor inhibitors. World J Cardiol. 2014;6(12):1278-84.
21 Marth T. Systematic review: whipple’s disease (Tropheryma whipplei infection) and its unmasking by tumour necrosis factor inhibitors. Aliment Pharmacol Ther. 2015;41(8):709-24.
22 Maresi E, Argo A, Portelli F, Busardò FP, Raoult D, Lepidi H. Rare occurrence of Whipple Disease in a young female patient with a fatal outcome. Egyptian Journal of Forensic Sciences. 2013;3(3):85-91.
23 Tandon P, Huang V, Jaffer N, Kirsch R, Croitoru K. A rare presentation of hypovolemic shock secondary to Whipple’s disease. Eur J Gastroenterol Hepatol. 2019;31(5):642-5.
24 Martinetti M, Biagi F, Badulli C, et al. The HLA alleles DRB1*13 and DQB1*06 are associated to Whipple’s disease. Gastroenterology. 2009;136(7):2289-94.
25 Ghigo E, Barry AO, Pretat L, et al. IL-16 promotes T. whipplei replication by inhibiting phagosome conversion and modulating macrophage activation. PLoS One. 2010;5(10):e13561.
26 Moos V, Kunkel D, Marth T, et al. Reduced peripheral and mucosal Tropheryma whipplei-specific Th1 response in patients with Whipple’s disease. J Immunol. 2006;177(3):2015-22.
27 Schinnerling K, Moos V, Geelhaar A, et al. Regulatory T cells in patients with Whipple’s disease. J Immunol. 2011;187(8):4061-7.
28 Schinnerling K, Geelhaar-Karsch A, Allers K, et al. Role of dendritic cells in the pathogenesis of Whipple’s disease. Infect Immun. 2015;83(2):482-91.
Submitted date:
09/02/2020
Accepted date:
10/01/2020
Publication date:
01/28/2021
Facebook
Google+
Twitter
LinkedIn
Mendeley
StumbleUpon
CiteULike
Reddit
Email